-
公开(公告)号:EP4302837A3
公开(公告)日:2024-05-01
申请号:EP23183858.2
申请日:2022-12-07
CPC分类号: A61K2800/52220130101 , A61P39/06 , A61K2800/5220130101 , A61Q19/00 , A61K8/64
摘要: The present invention relates to photostabilized compositions comprising a water-soluble tyrosine-containing compound with a molecular weight of below 1kDa and at least one photosensitive component and a method for stabilizing photosensitive components comprising the addition of a tyrosine-containing dipeptide.
-
公开(公告)号:EP4289936A1
公开(公告)日:2023-12-13
申请号:EP22749742.7
申请日:2022-02-02
摘要: Provided is a cell culture microcarrier capable of suppressing the aggregation of a microcarrier due to cell clumps and enhancing the efficiency of culturing cells. The cell culture microcarrier according to the present invention includes a base particle and a coating layer coating the outer surface of the base particle, and has a specific gravity of 1.10 g/cm 3 or more.
-
公开(公告)号:EP4116415A1
公开(公告)日:2023-01-11
申请号:EP22176401.2
申请日:2015-11-26
申请人: Neuro-Bio Ltd
摘要: The invention relates to novel peptides, compositions, therapies and methods for treating neurodegenerative disorders, for example Alzheimer's disease.
-
公开(公告)号:EP3250230B9
公开(公告)日:2022-02-23
申请号:EP16744125.2
申请日:2016-01-28
发明人: HOARTY, Michelle, Denise , DHAMNASKAR, Ketki, Ashok , ELBAUM, Daniel , JOSEPHSON, Kristopher , LARSON, Kelley, Cronin , MA, Zhong , NIMS, Nathan, Ezekiel , RICARDO, Alonso , SEYB, Kathleen , TANG, Guo-Qing , TRECO, Douglas, A. , WANG, Zhaolin , YE, Ping , ZHENG, Hong , PERLMUTTER, Sarah, Jacqueline
-
公开(公告)号:EP3936621A1
公开(公告)日:2022-01-12
申请号:EP21177974.9
申请日:2007-01-19
发明人: Possemato, Anthony , Guo, Ailan
摘要: In accordance with the invention, a novel gene translocation, (4p15, 6q22), in human non-small cell lung carcinoma (NSCLC) that results in a fusion proteins combining part of Sodium-dependent Phosphate Transporter lsoform NaPi-3b protein (SLC34A2) with Proto-oncogene Tyrosine Protein Kinase ROS Precursor (ROS) kinase has now been identified. The SLC34A2-ROS fusion protein is anticipated to drive the proliferation and survival of a subgroup of NSCLC tumors. The invention therefore provides, in part, isolated polynucleotides and vectors encoding the disclosed mutant ROS kinase polypeptides, probes for detecting it, isolated mutant polypeptides, recombinant polypeptides, and reagents for detecting the fusion and truncated polypeptides. The disclosed identification of the new fusion protein enables new methods for determining the presence of these mutant ROS kinase polypeptides in a biological sample, methods for screening for compounds that inhibit the proteins, and methods for inhibiting the progression of a cancer characterized by the mutant polynucleotides or polypeptides, which are also provided by the invention.
-
公开(公告)号:EP3868878A2
公开(公告)日:2021-08-25
申请号:EP20215603.0
申请日:2016-06-15
发明人: Miyamoto, Etsuko , Ozawa, Masaaki
摘要: Provided is method of degrading a target protein, the method comprising the step of inducing degradation of the target protein using a protein-degradation inducing tag, wherein the protein-degradation inducing tag is a molecule having an affinity with a protease without inhibiting degradation of the protein by the protease, wherein the protein-degradation inducing tag can lead the target protein to degradation by a protease without ubiquitina-tion of the target protein and wherein the protein-degradation inducing tag has a molecular weight within the range of 50 to 5000 g/mol.
-
7.
-
公开(公告)号:EP3474878A1
公开(公告)日:2019-05-01
申请号:EP17820998.7
申请日:2017-06-26
申请人: Yu, Ruey J. , Van Scott, Eugene J.
发明人: Yu, Ruey J. , Van Scott, Eugene J.
-
公开(公告)号:EP2491943B1
公开(公告)日:2018-10-10
申请号:EP11009660.9
申请日:2004-02-03
CPC分类号: A61K38/07 , A61K38/03 , C07K5/1008 , C07K5/1016 , C07K5/1019 , C07K5/1024
摘要: The invention provides a method of reducing or preventing mitochondrial permeability transitioning. The method comprises administering an effective amount of an aromatic-cationic peptide having at least one net positive charge; a minimum of four amino acids; a maximum of about twenty amino acids; a relationship between the minimum number of net positive charges (p m ) and the total number of amino acid residues (r) wherein 3p m is the largest number that is less than or equal to r + 1; and a relationship between the minimum number of aromatic groups (a) and the total number of net positive charges (p t ) wherein 2a is the largest number that is less than or equal to p t + 1, except that when a is 1, p t may also be 1.
-
10.
公开(公告)号:EP3374381A1
公开(公告)日:2018-09-19
申请号:EP16863266.9
申请日:2016-11-09
IPC分类号: C07K14/47 , A61K39/00 , A61K39/385 , A61K47/60 , A61K47/68 , A61K49/00 , A61K51/10 , A61P25/28 , A61P37/04 , C07K16/18 , C07K5/00 , C07K7/06 , C07K7/64 , C12N15/12 , C12N15/13 , C12N5/10 , G01N33/53 , G01N33/577
CPC分类号: C07K14/4711 , A61K38/00 , A61K39/0007 , A61K39/39 , A61K47/643 , A61K47/646 , A61K51/1018 , A61K2039/505 , A61K2039/55505 , A61K2039/6081 , A61P25/28 , C07K5/101 , C07K5/1024 , C07K7/06 , C07K7/64 , C07K16/18 , C07K2317/24 , C07K2317/56 , C07K2317/565 , C12N5/10 , G01N33/6896 , G01N2333/4709 , G01N2800/2821
摘要: The disclosure pertains to conformational epitopes in A-beta, antibodies thereto and methods of making and using immunogens and antibodies specific thereto.
-
-
-
-
-
-
-
-
-